Newsroom | 23046 results

NEWTON, Mass.--(BUSINESS WIRE)--4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program...

OXFORD, England--(BUSINESS WIRE)--ProImmune, Ltd., a global leader in immunological reagents and services, today announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a high-containment, infectious disease research facility, to develop innovative tools for studying high-consequence emerging and endemic infectious diseases. Under the agreement, ProImmune’s Ankyrons will be evaluated as molecular tools to enable precise detection, locali...

CAMBRIDGE, England--(BUSINESS WIRE)--ELRIG announces Drug Discovery USA 2026. The inaugural event takes place at Pfizer in Cambridge, MA from 16–17 June and is free to attend....

SAN FRANCISCO--(BUSINESS WIRE)--Protests: AHF Blasts Gilead Over Extortionate AIDS Drug Pricing...

WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) Global Public Health Institute and UNITE Parliamentarians Network for Global Health will convene a high-level parliamentary roundtable dialogue, Financing Health Equity and Security, on April 14 – a breakfast side event to the 2026 Spring Meetings of the International Monetary Fund and World Bank Group. The critical discussions will unite parliamentarians, global health leaders, and key stakeholders participating in the Spring Meetin...

BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--Orum Therapeutics Appoints Dr. Maria Koehler and Geoff Meyerson to Board of Directors...

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that the first participant has been dosed in a Phase 1 clinical trial of EDP-978, an oral, once-daily KIT inhibitor in development for urticaria and other mast cell-driven diseases. The Phase 1 single-ascending dose (SAD) and multiple-ascending dose (MAD) clinical trial wil...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its upcoming presence at the Infusion Nurses Society (INS) 2026 Annual Meeting taking place in Louisville, KY from April 11 – 14, 2026. The event will bring together leading clinicians, researchers, healthcare professionals and industry leaders all dedicated to advancing vascular access and infusion therapy practice. Attendees will have the opport...

SAN DIEGO--(BUSINESS WIRE)--FairJourney Bio (FJBio), a global antibody discovery contract research organization (CRO), today announced the opening of its advanced cryo-electron microscopy (cryo-EM) structural biology facility in San Diego, California. The new site significantly expands the Company’s presence in the US market and incorporates atomic-resolution structural biology directly into its antibody discovery platform. The facility houses a state-of-the-art 300 kV cryo-EM infrastructure, i...

DURHAM, N.C.--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today released “Still Here,” a social media video campaign designed to spark crucial conversations about HIV among young people. This launch coincides with National Youth HIV/AIDS Awareness Day and aims to confront the alarming reality that HIV remains a significant and often overlooked public health issue, especially among young people. While great progress h...